First American Trust’s Novartis NVS Stock Holding History

First American Trust’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$782K	Buy	5,123 +265	+5%	+$40.6K	0.05%	169
2025 Q4	$670K	Buy	4,858 +2	+0%	+$262	0.05%	175
2025 Q3	$623K	Buy	4,856 +1	+0%	+$122	0.05%	166
2025 Q2	$588K	Sell	4,855 -52	-1%	-$5.86K	0.05%	159
2025 Q1	$547K	Hold	4,907	–	–	0.05%	152
2024 Q4	$478K	Sell	4,907 -205	-4%	-$21.9K	0.05%	157
2024 Q3	$588K	Sell	5,112 -157	-3%	-$17.8K	0.06%	142
2024 Q2	$561K	Sell	5,269 -222	-4%	-$22.3K	0.06%	134
2024 Q1	$531K	Buy	5,491 +202	+4%	+$20.7K	0.06%	139
2023 Q4	$534K	Buy	5,289 +361	+7%	+$34.8K	0.07%	122
2023 Q3	$502K	Sell	4,928 -60	-1%	-$6.09K	0.07%	107
2023 Q2	$503K	Buy	4,988 +106	+2%	+$10.6K	0.07%	108
2023 Q1	$449K	Hold	4,882	–	–	0.07%	113
2022 Q4	$443K	Buy	4,882 +98	+2%	+$8.25K	0.07%	113
2022 Q3	$364K	Hold	4,784	–	–	0.06%	113
2022 Q2	$404K	Sell	4,784 -337	-7%	-$29.6K	0.06%	114
2022 Q1	$449K	Buy	5,121 +737	+17%	+$63.8K	0.06%	113
2021 Q4	$383K	Hold	4,384	–	–	0.05%	121
2021 Q3	$359K	Hold	4,384	–	–	0.05%	122
2021 Q2	$400K	Sell	4,384 -7	-0.2%	-$623	0.06%	111
2021 Q1	$375K	Sell	4,391 -32	-0.7%	-$2.87K	0.06%	120
2020 Q4	$418K	Hold	4,423	–	–	0.07%	105
2020 Q3	$385K	Hold	4,423	–	–	0.07%	105
2020 Q2	$386K	Buy	4,423 +39	+0.9%	+$3.37K	0.08%	97
2020 Q1	$361K	Hold	4,384	–	–	0.09%	89
2019 Q4	$415K	Hold	4,384	–	–	0.08%	99
2019 Q3	$381K	Hold	4,384	–	–	0.08%	93
2019 Q2	$400K	Sell	4,384 -509	-10%	-$43.1K	0.08%	90
2019 Q1	$421K	Hold	4,893	–	–	0.09%	84
2018 Q4	$376K	Hold	4,893	–	–	0.09%	85
2018 Q3	$378K	Sell	4,893 -334	-6%	-$24.7K	0.08%	89
2018 Q2	$354K	Buy	5,227 +334	+7%	+$23K	0.08%	100
2018 Q1	$354K	Sell	4,893 -44	-0.9%	-$3.35K	0.09%	98
2017 Q4	$371K	Sell	4,937 -56	-1%	-$4.22K	0.09%	94
2017 Q3	$384K	Buy	4,993 +100	+2%	+$7.55K	0.1%	86
2017 Q2	$366K	Hold	4,893	–	–	0.1%	87
2017 Q1	$326K	Sell	4,893 -89	-2%	-$5.93K	0.1%	88
2016 Q4	$325K	Buy	4,982 +89	+2%	+$5.77K	0.1%	89
2016 Q3	$346K	Sell	4,893 -1,005	-17%	-$73.2K	0.11%	87
2016 Q2	$436K	Sell	5,898 -703	-11%	-$48.6K	0.15%	81
2016 Q1	$429K	Sell	6,601 -34	-0.5%	-$2.31K	0.15%	84
2015 Q4	$511K	Hold	6,635	–	–	0.19%	80
2015 Q3	$547K	Hold	6,635	–	–	0.21%	75
2015 Q2	$585K	Buy	6,635 +108	+2%	+$9.91K	0.22%	75
2015 Q1	$576K	Hold	6,527	–	–	0.21%	74
2014 Q4	$542K	Hold	6,527	–	–	0.2%	73
2014 Q3	$551K	Hold	6,527	–	–	0.2%	72
2014 Q2	$530K	Buy	6,527 +1,634	+33%	+$129K	0.2%	68
2014 Q1	$373K	Sell	4,893 -1,224	-20%	-$89.2K	0.14%	76
2013 Q4	$440K	Buy	6,117 +11	+0.2%	+$765	0.15%	90
2013 Q3	$420K	Sell	6,106 -84	-1%	-$5.56K	0.15%	86
2013 Q2	$392K	Buy	+6,190	New	+$403K	0.15%	89

Other funds holding NVS

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First American Trust's NVS Position: Q1 2026 in Review

First American Trust increased its Novartis (NVS) stake by 5.5% in Q1 2026, buying an estimated $40.6K and bringing the position to 5,123 shares worth $782K. The position accounts for 0.05% of the portfolio, ranked #169.

First American Trust first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

First American Trust held 5,123 shares of Novartis worth $782K as of Q1 2026.
First American Trust bought 265 Novartis shares in Q1 2026, an estimated $40.6K.
Novartis made up 0.05% of First American Trust's portfolio in Q1 2026, its #169 holding.
First American Trust first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on First American Trust's 13F filing for Q1 2026, filed 12 May 2026.